- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00266448
Whole Body Washing With Chlorhexidine for the Eradication of MRSA
The Value of Whole Body Washing With Chlorhexidine for the Eradication of MRSA - a Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The number and rate of infections due to meticillin-resistant Staphylococcus aureus (MRSA)is increasing world wide. Patients who are colonized with MRSA are the main source for further distribution. In addition colonization with MRSA is a precondition for infection.
Whole body washing with antiseptic solutions as part of eradication strategies for MRSA has been widely used. However, there is insufficient evidence to support use of topical antimicrobial therapy for eradicating of MRSA because treatment with antiseptic solution has never been compared to placebo.
Comparison: The efficacy of whole body washing in the control of MRSA was studied in a randomized, placebo-controlled, double-blinded clinical trial. The study treatment consisted of five days of whole body washing either with 4% chlorhexidine solution (verum) or with placebo. All patients received mupirocin nasal ointment and chlorhexidine mouth rinse. The outcome was evaluated 3, 4, 5, 9 and 30 days after treatment by swabs taken from several body site.
Study Type
Enrollment
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Heidelberg, Germany, 69120
- University Hospital Heidelberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- persons who are colonized with MRSA, i.e. one or more cultures from any body site yielded MRSA
Exclusion Criteria:
- ongoing systemic or local antimicrobial treatment directed against MRSA
- hypersensitivity to mupirocin or chlorhexidine
- pregnancy
- previous enrolment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
efficacy of a whole body treatment with chlorhexidine in eradicating overall MRSA carriage
|
Secondary Outcome Measures
Outcome Measure |
---|
development of MRSA infection
|
tolerance to the antiseptic whole body treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Constanze Wendt, MD, MSc, Hygiene-Institut University Hospital Heidelberg
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 94/2000
- Projekt-Nr. 384/2000
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MRSA-Colonization
-
Hvidovre University HospitalRecruiting
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyCompletedMRSA Colonization | VRE ColonizationTurkey
-
Massachusetts General HospitalCompletedMRSA ColonizationUnited States
-
Rothman Institute OrthopaedicsUnknown
-
University of British ColumbiaUnknownNasal Colonization With MRSA BacteriaCanada
-
University of TennesseeUnited States Department of DefenseCompleted
-
Hunter Holmes Mcguire Veteran Affairs Medical CenterCenters for Disease Control and Prevention; Sage Products, Inc.UnknownMRSA Infection | MRSA Colonization | VRE Infection | VRE Colonization | Nosocomial BacteremiaUnited States
-
Hunter Holmes Mcguire Veteran Affairs Medical CenterJohns Hopkins University; Washington University School of Medicine; Weill Medical... and other collaboratorsCompletedMRSA Infection | MRSA Colonization | VRE Infection | VRE Colonization | Nosocomial Bacteremia | Nosocomial FungemiaUnited States
-
B. Braun Medical SATerminatedMRSA - Methicillin Resistant Staphylococcus Aureus Infection | MRSA ColonizationSpain
-
Rennes University HospitalMinistry of Health, FranceCompletedNosocomial Infections | MRSA ColonizationFrance
Clinical Trials on Chlorhexidine solution 4%
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Annamalai University; Ministry of Health and...CompletedOmphalitis | Neonatal Mortality | Cord CareTanzania
-
University Of PerugiaFondazione Toscana Gabriele MonasterioCompleted
-
Angela BiancoStryker NordicTerminatedCesarean Section | Surgical Site Infection | Nosocomial InfectionUnited States
-
Eunice Kennedy Shriver National Institute of Child...United States Agency for International Development (USAID); Bill and Melinda...CompletedNeonatal MortalityUnited States, Nepal
-
Damascus UniversityCompletedDental Caries | Infection, Bacterial | Tooth, DeciduousSyrian Arab Republic
-
Yaneve FongeRecruitingSurgical Site Infection | Cesarean Section; InfectionUnited States
-
Medline IndustriesCompleted
-
Aga Khan UniversityJohn Snow, Inc.Completed
-
Mahidol UniversityActive, not recruitingMicrobial Disease | MetabolomicsThailand
-
Okan UniversityCompletedSkin | Health Care Associated InfectionTurkey